2 completed, 2 terminated, 1 active not recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 2, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Myoclonus: new trials by email Literature Review of Myoclonus trials Research Report on Myoclonus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Anti-Thymocyte Globulin, Autologous Hematopoietic Stem Cell Transplantation, Carmustine - Autoimmune Disease, Neurologic Autoimmune Disease | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 53 | 2008-06-01 | 2026-02-27 |
| Pilot Efficacy Study of T2000 in Myoclonus Dystonia T2000 - Myoclonus | Phase 2 | Terminated | Sun Pharmaceutical Industries, Inc. | 5 | 2007-08-01 | 2013-12-23 |
| Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma anti-CD20 (Rituximab) - Neuroblastoma, Opsoclonus-myoclonus | Phase 2 | Terminated | Jean M. Tersak, M.D. | 4 | 2005-07-01 | 2021-01-22 |
| Effectiveness of Rituximab in Pediatric OMS Patients. rituximab - Opsoclonus-myoclonus Syndrome, Opsoclonus | Phase 1 / Phase 2 | Completed | National Pediatric Neuroinflammation Organization, Inc. | 25 | 2005-06-01 | 2011-05-10 |
| OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease OGT 918 - Gaucher Disease | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 30 | 2002-07-05 | 2017-07-02 |
Opsoclonus-Myoclonus Syndrome (3) · Ataxia (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Dyskinesias (1) · Gaucher Disease (1) · Lambert-Eaton Myasthenic Syndrome (1) · Movement Disorders (1) · Myasthenia Gravis (1) · Myoclonic dystonia (1) · Neuroblastoma (1) · Neuromyelitis Optica (1) · Ocular Motility Disorders (1) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
Central Nervous System Diseases (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Dyskinesias (4) · Pathological Conditions, Signs and Symptoms (4) · Cranial Nerve Diseases (3) · Eye Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Nervous System Neoplasms (3) · Neurodegenerative Diseases (3) · Paraneoplastic Syndromes (3) · Paraneoplastic Syndromes, Nervous System (3) · Signs and Symptoms (3) · Brain Diseases (2)
Rituximab (2) · Antilymphocyte Serum (1) · Carmustine (1) · Cytarabine (1) · Etoposide (1) · Melphalan (1) · Peripheral Blood Stem Cell Transplantation (1) · Prednisone (1) · carmustine, poliferprosan 20 drug combination (1) · deltacortene (1) · miglustat (1) · prednylidene (1) · thymoglobulin (1)
Fred Hutchinson Cancer Center (1) · Jean M. Tersak, M.D. (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Pediatric Neuroinflammation Organization, Inc. (1) · Sun Pharmaceutical Industries, Inc. (1)
United States (3) · Canada (1) · United Kingdom (1)
Jean M Tersak, M.D. (1) · Leona Holmberg (1) · Michael R Pranzatelli, M.D. (1)